What can we expect for adolescents and adults with haemophilia switched to low‐dose prophylaxis from episodic treatment for over 3 years? A real‐world snapshot in China-Reference-Cited by-同舟云学术

What can we expect for adolescents and adults with haemophilia switched to low‐dose prophylaxis from episodic treatment for over 3 years? A real‐world snapshot in China

Published:2021-06-12 Issue:5 Volume:27 Page:
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Liu Sha¹^ORCID,Zhang Ping‐yang²,Jin Zhi‐bin¹,Yuan Yan‐hui³,Wu Min¹,Zhou Rong‐fu³

Affiliation:

1. Department of Ultrasound, Affiliated Drum Tower Hospital Medical School of Nanjing University Nanjing Jiangsu China

2. Department of Ultrasound Medicine, Nanjing First Hospital Nanjing Medical University Nanjing Jiangsu China

3. Department of Hematology, Affiliated Drum Tower Hospital Medical School of Nanjing University Nanjing Jiangsu China

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14361

Reference15 articles.

1. Prophylactic treatment for hemophilia A patients: a pilot study;Chuansumrit A;Southeast Asian J Trop Med Public Health,1995

2. Beyond the bleeding rates‐ HEAD‐US joint assessment in patients treated by late prophylaxis

3. Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

4. A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)

5. A prospective study of health-related quality of life of boys with severe haemophilia A in China: comparing on-demand to prophylaxis treatment

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Report on the diagnosis and treatment of hemophilia in China (Version 2024);LabMed Discovery;2024-07

2. Low‐dose prophylaxis and its impact on the health of haemophilia patients;Vox Sanguinis;2022-04-18